一个国际的Delphi共识报告的设置在迷幻的临床试验
Chloé Pronovost-Morgan1,2,3, Kyle T Greenway4,5,6, Leor Roseman7,8
1Faculty of Medicine and Health Sciences, McGill University, Montreal, Quebec, Canada. chloe.pronovost-morgan@mail.mcgill.ca.
Nature medicine
|June 3, 2025
概括
新的指导方针标准化了迷幻药物临床试验的报告. 心理测试临床试验 (ReSPCT) 准则的报告确保了关键背景的一致记录,提高了研究的严谨性.
科学领域:
- 心理药理学 心理药理学
- 临床研究方法论 临床研究方法论
背景情况:
- 迷幻药物与使用者的精神状态 ("设置") 和环境 ("设置") 显著相互作用.
- 现有的迷幻药研究往往缺乏方法论的严格性来报告这些关键的非药理学因素.
- 需要标准化的报告来提高迷幻药物临床试验的质量和可重复性.
研究的目的:
- 为了产生基于共识的指导方针,报告心理临床研究中的设置变量.
- 建立一个标准化的框架,用于记录心理研究中的环境和上下文因素.
- 在研究中解决当前对"设置和设置"的概念化中的模两可.
主要方法:
- 德尔菲共识研究涉及四轮在线调查,涉及89名国际专家 (研究人员,临床医生,过去的试验参与者).
- 专家们确定,评价,辩论并改进了潜在重要的迷幻设置变量.
- 对于≥70%的专家来说,共识被定义为"重要"或"非常重要".
主要成果:
- 30个非药理学变量达到了共识,并形成了心理临床试验 (ReSPCT) 中设置报告指南.
- ReSPCT指南分为物理环境,剂量治疗程序,治疗框架/协议和主观经验.
- 该研究发现,目前在迷幻研究中对"设置和设置"的理解存在显著的模两可.
结论:
- ReSPCT指导方针为在迷幻药临床研究中设计和记录非药理学变量的新标准.
- 遵守这些准则将提高迷幻研究的方法严谨性和一致性.
- 这些指导方针旨在提高幻觉药物临床试验结果的整体质量和解释性.
相关概念视频
Pharmacovigilance
1.0K
Post-marketing surveillance is a critical component of pharmaceutical regulation, often uncovering unanticipated adverse drug reactions (ADRs) once a drug is widely used over an extended period.
This process, termed pharmacovigilance, aims to detect, evaluate, and minimize harmful effects related to medication use. The data collection for pharmacovigilance depends on spontaneous reporting systems, where healthcare professionals or patients voluntarily report suspected ADRs.
In some cases, there...
This process, termed pharmacovigilance, aims to detect, evaluate, and minimize harmful effects related to medication use. The data collection for pharmacovigilance depends on spontaneous reporting systems, where healthcare professionals or patients voluntarily report suspected ADRs.
In some cases, there...
1.0K
Clinical Trials
9.3K
Clinical trials are prospective experimental studies conducted on humans to determine the safety and efficacy of treatments, drugs, diet methods, and medical devices. Using statistics in clinical trials enables researchers to derive reasonable and accurate conclusions from the collected data, allowing them to make wise decisions in uncertain situations. In medical research, statistical methods are crucial for preventing errors and bias.
There are four phases in a clinical trial. A phase one...
There are four phases in a clinical trial. A phase one...
9.3K
Types of Reports II: Incident or Occurrence Report
958
An Incident or Occurrence Report in a healthcare setting is a crucial document used to record any unexpected occurrence that may or may not have affected a patient, employee, or visitor. Such reports are critical to improving patient safety and include all details leading up to and including the event.
Purposes:
In the healthcare industry, reports play a crucial role in documenting incidents within an agency. The primary objective of these reports is to ensure patient safety, uphold the...
Purposes:
In the healthcare industry, reports play a crucial role in documenting incidents within an agency. The primary objective of these reports is to ensure patient safety, uphold the...
958
Clinical Trials: Overview
3.4K
Clinical development focuses on how the drug will interact with the human body and encompasses four key phases of clinical trials, each serving a specific purpose in assessing the safety and effectiveness of new drugs. These phases overlap and build upon one another. Phase I involves a small group of healthy volunteers (typically 20-80 individuals) or, in cases where significant toxicity is expected, patients with the targeted disease, such as cancer or AIDS. The volunteers are tested for...
3.4K
Ethics in Research
24.1K
Today, scientists agree that good research is ethical in nature and is guided by a basic respect for human dignity and safety. However, this has not always been the case. Modern researchers must demonstrate that the research they perform is ethically sound.
24.1K
Preclinical Development: Overview
4.9K
Preclinical development consists of a series of tests that ensure the safety and efficacy of a new therapeutic compound before it is tested in humans. There are four main phases to this process. First, safety pharmacology tests are conducted to ensure the drug does not produce any acutely harmful effects. These tests examine parameters such as bronchoconstriction, cardiac dysrhythmias, blood pressure changes, and ataxia. Next, preliminary toxicological testing is performed to determine the...
4.9K


